Clin2
NCT06798948Possibly a fitRecruiting

Can a mix of herbs improve mild fatty liver?

Metabolic-associated Fatty Liver Disease (MAFLD)

Part of Digestive system, Hormones & metabolism clinical trials.

This study is testing if a combination of four herbs (artichoke, milk thistle, turmeric, and licorice root) can help people with non-alcoholic mild to moderate fatty liver disease (also called metabolic-associated fatty liver disease). It's a randomized trial, meaning participants are assigned to either the herbal mix or a comparison group. This may offer a natural option to support liver health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have been diagnosed with mild to moderate fatty liver disease (not caused by alcohol).
  • You are between 18 and 65 years old.
  • You have not taken any liver-protecting supplements or medicines in the past 3 months.
  • You are willing to stop any other liver-support products and follow the study plan.
  • You do not have other liver diseases, like hepatitis or cirrhosis, or serious health conditions like cancer, HIV, or uncontrolled diabetes or high blood pressure.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07592013Enrolling by invitation
Ancestry Supplements for Fatty Liver Disease

This study tests whether a special supplement (made from cacao, nopal, and crickets) can help improve fatty liver disease in people with excess body fat. Fatty liver disease happens when fat builds up in the liver, and this trial investigates whether these natural ingredients can reduce that buildup.

Guadalajara, Guadalajara
NCT07193927Recruiting· Phase 2
Testing a probiotic mix for fatty liver disease (MASLD)

This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.

Girona, Girona
NCT06585982Recruiting
Synbiotics for MAFLD: gut health and liver fat study

This trial tests whether taking a synbiotic (a mix of helpful bacteria and fiber) can improve insulin levels and reduce inflammation in people with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). It may help by changing the balance of bacteria in your gut.

Semarang, Semarang
NCT07637006Not yet recruiting· Phase 2
Chinese herbal capsule for fatty liver disease

This trial tests a traditional Chinese herbal capsule (Linzhi Jianghuang Fufang) to treat non-alcoholic fatty liver disease—a buildup of fat in the liver not caused by alcohol. The study aims to see if this herbal treatment can safely reduce liver fat and improve metabolic health in people with early-stage fatty liver.

NCT07025980Not yet recruiting· Phase 2
Probiotics for fatty liver disease

This trial tests whether a special mix of probiotics can help improve liver health in people with fatty liver disease related to metabolism. It measures changes in liver enzymes, fat, and stiffness over time.

Šibenik, Croatia
NCT03503708Not yet recruiting
Herbal supplements for liver function in alcohol-related liver disease

This trial tests whether specific herbal supplements can improve liver health in adults with alcohol-related liver disease. It aims to see if the supplement safely improves liver blood tests and overall liver function.

Bangalore, Karnataka

Hear when a new Metabolic-associated Fatty Liver Disease (MAFLD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.